Filing Details

Accession Number:
0001562180-18-003498
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-06 18:17:13
Reporting Period:
2018-08-03
Accepted Time:
2018-08-06 18:17:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1560241 G1 Therapeutics Inc. GTHX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274071 L Terry Murdock 79 T.w. Alexander Drive
4501 Research Commons, Suite 100
Research Triangle Park NC 27709
Svp Of Development Operations No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-03 3,519 $13.51 3,519 No 4 M Direct
Common Stock Disposition 2018-08-03 3,519 $50.60 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2018-08-03 3,519 $0.00 3,519 $13.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
96,481 2027-08-01 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  2. The shares underlying this option vested as to 25% of the shares on August 1, 2018, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.